Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Atrial Fibrillation Risk Estimation With Single-lead Handheld Electrocardiograms [NA]

View source ↗

Summary

This clinical trial update notes ongoing enrollment for a study estimating atrial fibrillation risk using a single-lead handheld electrocardiogram.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Atrial Fibrillation (AF) | NA | Status: ENROLLING_BY_INVITATION